Shares of Proteome Sciences plc (LON:PRM – Get Free Report) fell 8.9% during mid-day trading on Friday . The company traded as low as GBX 2.70 ($0.04) and last traded at GBX 3.18 ($0.04). 212,487 shares traded hands during trading, an increase of 26% from the average session volume of 168,918 shares. The stock had previously closed at GBX 3.49 ($0.05).
Proteome Sciences Stock Performance
The firm has a market cap of £9.39 million, a P/E ratio of -360.00 and a beta of 0.07. The company’s 50 day moving average is GBX 3.38 and its 200 day moving average is GBX 3.57.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Leveraged ETFs to Multiply Returns
- 3 Warren Buffett Stocks to Buy Now
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Following Congress Stock Trades
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
